Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 6/20 | 0.62 |
| ▸ | JAK2 | O60674 | 4/20 | 0.62 |
| ▸ | JAK1 | P23458 | 4/20 | 0.62 |
| ▸ | JAK3 | P52333 | 4/20 | 0.62 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 5/20 | 0.35 |
| ▸ | ABL1 | P00519 | 3/20 | 0.33 |
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.33 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.33 |
| ▸ | BRAF | P15056 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | WNT1 | P04628 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18409117 | 0.92 | TYK2 (0.55) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18409322 | 0.89 | TYK2 (0.53) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18409286 | 0.89 | JAK2 (0.47) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18409108 | 0.89 | JAK1 (0.47) | TYK2JAK2JAK1JAK3ABL1 | |
| SCHEMBL16909321 | 0.86 | TYK2 (0.60) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18398581 | 0.85 | JAK2 (0.53) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18409202 | 0.84 | TYK2 (0.53) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18409170 | 0.83 | TYK2 (0.61) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18409163 | 0.83 | TYK2 (0.75) | TYK2JAK2JAK1JAK3EGLN2 | |
| SCHEMBL18398396 | 0.81 | JAK1 (0.44) | TYK2JAK2JAK1JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017012647-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | GALAPAGOS NV (BE) | 2017-01-26 | — | — | WO | disclosed |